These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1362537)

  • 21. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.
    Dahl ML; Johansson I; Bertilsson L; Ingelman-Sundberg M; Sjöqvist F
    J Pharmacol Exp Ther; 1995 Jul; 274(1):516-20. PubMed ID: 7616439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Debrisoquine metabolism and lung cancer risk.
    Shaw GL; Falk RT; Deslauriers J; Frame JN; Nesbitt JC; Pass HI; Issaq HJ; Hoover RN; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):41-8. PubMed ID: 7894323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The sparteine/debrisoquine (CYP2D6) oxidation polymorphism and the risk of lung cancer: a meta-analysis.
    Christensen PM; Gøtzsche PC; Brøsen K
    Eur J Clin Pharmacol; 1997; 51(5):389-93. PubMed ID: 9049580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype.
    Caporaso N; Hayes RB; Dosemeci M; Hoover R; Ayesh R; Hetzel M; Idle J
    Cancer Res; 1989 Jul; 49(13):3675-9. PubMed ID: 2731181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Debrisoquine hydroxylase (CYP2D6) and prostate cancer.
    Febbo PG; Kantoff PW; Giovannucci E; Brown M; Chang G; Hennekens CH; Stampfer M
    Cancer Epidemiol Biomarkers Prev; 1998 Dec; 7(12):1075-8. PubMed ID: 9865424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Debrisoquine polymorphism: novel CYP2D6 gene Bam HI restriction fragment length polymorphism in the Ngawbé Guaymí Indian of Panama.
    Petersen DD; Kong AN; Jorge LF; Nebert DW; Arias TD
    Pharmacogenetics; 1991 Dec; 1(3):136-42. PubMed ID: 1688244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Xbal 16- plus 9-kilobase DNA restriction fragments identify a mutant allele for debrisoquin hydroxylase: report of a family study.
    Evans WE; Relling MV
    Mol Pharmacol; 1990 May; 37(5):639-42. PubMed ID: 1971090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk.
    Roots I; Drakoulis N; Ploch M; Heinemeyer G; Loddenkemper R; Minks T; Nitz M; Otte F; Koch M
    Klin Wochenschr; 1988; 66 Suppl 11():87-97. PubMed ID: 2846954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steady state concentrations of the enantiomers of mianserin and desmethylmianserin in poor and in homozygous and heterozygous extensive metabolizers of debrisoquine.
    Eap CB; Lima CA; Macciardi F; Woggon B; Powell K; Baumann P
    Ther Drug Monit; 1998 Feb; 20(1):7-13. PubMed ID: 9485547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of debrisoquine and 4-hydroxydebrisoquine by high-performance liquid chromatography: application to the evaluation of CYP2D6 genotype and debrisoquine metabolic ratio relationship.
    Dorado P; Berecz R; Cáceres MC; González I; Cobaleda J; Llerena A
    Clin Chem Lab Med; 2005; 43(3):275-9. PubMed ID: 15843230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analysis of the interethnic difference between Chinese and Caucasians in the polymorphic metabolism of debrisoquine and codeine.
    Johansson I; Yue QY; Dahl ML; Heim M; Säwe J; Bertilsson L; Meyer UA; Sjöqvist F; Ingelman-Sundberg M
    Eur J Clin Pharmacol; 1991; 40(6):553-6. PubMed ID: 1679392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between haloperidol plasma concentration, debrisoquine metabolic ratio, CYP2D6 and CYP2C9 genotypes in psychiatric patients.
    LLerena A; de la Rubia A; Berecz R; Dorado P
    Pharmacopsychiatry; 2004 Mar; 37(2):69-73. PubMed ID: 15048614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a link between debrisoquine oxidation phenotype and lung cancer susceptibility?
    Horsmans Y; Desager JP; Harvengt C
    Biomed Pharmacother; 1991; 45(8):359-62. PubMed ID: 1773024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics of debrisoquine and its use as a marker for CYP2D6 hydroxylation capacity.
    Llerena A; Dorado P; Peñas-Lledó EM
    Pharmacogenomics; 2009 Jan; 10(1):17-28. PubMed ID: 19102711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of CYP2D6*3 and 2D6*4 allelic variants by PCR-restriction fragment length polymorphism.
    Topić E; Stefanović M; Nikolić V; Zoricić I; Ivanisević AM; Zuntar I
    Clin Chem Lab Med; 1998 Aug; 36(8):655-8. PubMed ID: 9806480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects.
    Relling MV; Cherrie J; Schell MJ; Petros WP; Meyer WH; Evans WE
    Clin Pharmacol Ther; 1991 Sep; 50(3):308-13. PubMed ID: 1680593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung tumor resection does not affect debrisoquine metabolism.
    Shaw GL; Falk RT; Deslauriers J; Nesbitt JC; McKneally MF; Frame JN; Feld R; Issaq HJ; Ruckdeschel JC; Hoover RN
    Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):141-4. PubMed ID: 8049635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotyping of poor metabolisers of debrisoquine by allele-specific PCR amplification.
    Heim M; Meyer UA
    Lancet; 1990 Sep; 336(8714):529-32. PubMed ID: 1975039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic oxidation phenotypes as markers for susceptibility to lung cancer.
    Ayesh R; Idle JR; Ritchie JC; Crothers MJ; Hetzel MR
    Nature; 1984 Nov 8-14; 312(5990):169-70. PubMed ID: 6504125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Debrisoquine oxidation phenotype during neuroleptic monotherapy.
    Spina E; Martines C; Caputi AP; Cobaleda J; Piñas B; Carrillo JA; Benitez J
    Eur J Clin Pharmacol; 1991; 41(5):467-70. PubMed ID: 1684751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.